Joe Raedle/Getty Images News
Boston Scientific (BSX) announced on Tuesday that its SEISMIQ 4CE catheter, an intravascular lithotripsy device designed to fracture calcium within coronary arteries, has been successful in a clinical study for patients with calcified coronary artery disease.
The pivotal FRACTURE Investigational
